

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.84932240 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 5.84932240 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.32613051 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.32613051 |
| 5 | exogenous drug catabolic process (GO:0042738) | 4.78861482 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 4.70914765 |
| 7 | blood coagulation, intrinsic pathway (GO:0007597) | 4.59885163 |
| 8 | epoxygenase P450 pathway (GO:0019373) | 4.29143961 |
| 9 | intestinal cholesterol absorption (GO:0030299) | 4.22103320 |
| 10 | low-density lipoprotein particle remodeling (GO:0034374) | 4.17796468 |
| 11 | bile acid biosynthetic process (GO:0006699) | 4.01723102 |
| 12 | omega-hydroxylase P450 pathway (GO:0097267) | 3.95566605 |
| 13 | * embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.82659426 |
| 14 | fibrinolysis (GO:0042730) | 3.81638941 |
| 15 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.78359542 |
| 16 | kynurenine metabolic process (GO:0070189) | 3.78320947 |
| 17 | indole-containing compound catabolic process (GO:0042436) | 3.74770929 |
| 18 | indolalkylamine catabolic process (GO:0046218) | 3.74770929 |
| 19 | tryptophan catabolic process (GO:0006569) | 3.74770929 |
| 20 | cellular glucuronidation (GO:0052695) | 3.74299515 |
| 21 | regulation of plasminogen activation (GO:0010755) | 3.71942534 |
| 22 | glyoxylate metabolic process (GO:0046487) | 3.64824423 |
| 23 | ethanol oxidation (GO:0006069) | 3.64442577 |
| 24 | alpha-linolenic acid metabolic process (GO:0036109) | 3.61808991 |
| 25 | tryptophan metabolic process (GO:0006568) | 3.55299336 |
| 26 | bile acid metabolic process (GO:0008206) | 3.51747023 |
| 27 | response to phenylpropanoid (GO:0080184) | 3.51565827 |
| 28 | high-density lipoprotein particle remodeling (GO:0034375) | 3.50829561 |
| 29 | glutamate metabolic process (GO:0006536) | 3.47445622 |
| 30 | fatty acid elongation (GO:0030497) | 3.46653458 |
| 31 | cellular ketone body metabolic process (GO:0046950) | 3.46621552 |
| 32 | uronic acid metabolic process (GO:0006063) | 3.46381171 |
| 33 | glucuronate metabolic process (GO:0019585) | 3.46381171 |
| 34 | plasma lipoprotein particle organization (GO:0071827) | 3.45434246 |
| 35 | protein activation cascade (GO:0072376) | 3.44723058 |
| 36 | coenzyme catabolic process (GO:0009109) | 3.43645513 |
| 37 | plasma lipoprotein particle assembly (GO:0034377) | 3.42226276 |
| 38 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.39086050 |
| 39 | regulation of protein activation cascade (GO:2000257) | 3.38766864 |
| 40 | regulation of fibrinolysis (GO:0051917) | 3.35379053 |
| 41 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.33690863 |
| 42 | detection of light stimulus involved in visual perception (GO:0050908) | 3.33690863 |
| 43 | tyrosine metabolic process (GO:0006570) | 3.33341112 |
| 44 | homocysteine metabolic process (GO:0050667) | 3.32594787 |
| 45 | negative regulation of fibrinolysis (GO:0051918) | 3.31333317 |
| 46 | axon ensheathment in central nervous system (GO:0032291) | 3.30866386 |
| 47 | central nervous system myelination (GO:0022010) | 3.30866386 |
| 48 | complement activation, alternative pathway (GO:0006957) | 3.29438832 |
| 49 | drug metabolic process (GO:0017144) | 3.26957688 |
| 50 | aromatic amino acid family metabolic process (GO:0009072) | 3.26353967 |
| 51 | triglyceride homeostasis (GO:0070328) | 3.25058385 |
| 52 | acylglycerol homeostasis (GO:0055090) | 3.25058385 |
| 53 | protein carboxylation (GO:0018214) | 3.24279719 |
| 54 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.24279719 |
| 55 | urea cycle (GO:0000050) | 3.22965178 |
| 56 | urea metabolic process (GO:0019627) | 3.22965178 |
| 57 | protein-lipid complex subunit organization (GO:0071825) | 3.21874524 |
| 58 | negative regulation of blood coagulation (GO:0030195) | 3.20927017 |
| 59 | negative regulation of hemostasis (GO:1900047) | 3.20927017 |
| 60 | alpha-amino acid catabolic process (GO:1901606) | 3.15336601 |
| 61 | regulation of apoptotic cell clearance (GO:2000425) | 3.14405907 |
| 62 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.12639991 |
| 63 | regulation of humoral immune response (GO:0002920) | 3.11750249 |
| 64 | regulation of complement activation (GO:0030449) | 3.11221964 |
| 65 | * regulation of bile acid biosynthetic process (GO:0070857) | 3.11083093 |
| 66 | oxidative demethylation (GO:0070989) | 3.09242136 |
| 67 | negative regulation of complement activation (GO:0045916) | 3.06534723 |
| 68 | dicarboxylic acid catabolic process (GO:0043649) | 3.06326613 |
| 69 | reverse cholesterol transport (GO:0043691) | 3.06319447 |
| 70 | complement activation, classical pathway (GO:0006958) | 3.02767418 |
| 71 | cysteine metabolic process (GO:0006534) | 3.01406182 |
| 72 | protein-lipid complex assembly (GO:0065005) | 2.99389893 |
| 73 | cholesterol efflux (GO:0033344) | 2.98725129 |
| 74 | ketone body metabolic process (GO:1902224) | 2.98290123 |
| 75 | plasma lipoprotein particle remodeling (GO:0034369) | 2.96053523 |
| 76 | protein-lipid complex remodeling (GO:0034368) | 2.96053523 |
| 77 | macromolecular complex remodeling (GO:0034367) | 2.96053523 |
| 78 | nitrogen cycle metabolic process (GO:0071941) | 2.95559068 |
| 79 | regulation of triglyceride catabolic process (GO:0010896) | 2.95423391 |
| 80 | short-chain fatty acid metabolic process (GO:0046459) | 2.94856839 |
| 81 | negative regulation of coagulation (GO:0050819) | 2.94320446 |
| 82 | aspartate family amino acid catabolic process (GO:0009068) | 2.94302195 |
| 83 | negative regulation of protein activation cascade (GO:2000258) | 2.93656315 |
| 84 | negative regulation of wound healing (GO:0061045) | 2.93119895 |
| 85 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.92680220 |
| 86 | acute-phase response (GO:0006953) | 2.90922775 |
| 87 | plasma lipoprotein particle clearance (GO:0034381) | 2.89378981 |
| 88 | complement activation (GO:0006956) | 2.88985966 |
| 89 | lysine catabolic process (GO:0006554) | 2.88182447 |
| 90 | lysine metabolic process (GO:0006553) | 2.88182447 |
| 91 | cellular amino acid catabolic process (GO:0009063) | 2.84913895 |
| 92 | sodium-independent organic anion transport (GO:0043252) | 2.84731383 |
| 93 | bile acid and bile salt transport (GO:0015721) | 2.83982122 |
| 94 | regulation of cholesterol esterification (GO:0010872) | 2.83472323 |
| 95 | negative regulation of lipase activity (GO:0060192) | 2.83414170 |
| 96 | peptidyl-glutamic acid modification (GO:0018200) | 2.82824238 |
| 97 | indolalkylamine metabolic process (GO:0006586) | 2.82121903 |
| 98 | phenylpropanoid metabolic process (GO:0009698) | 2.81461881 |
| 99 | very long-chain fatty acid metabolic process (GO:0000038) | 2.80946231 |
| 100 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.80409556 |
| 101 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.75279992 |
| 102 | ethanol metabolic process (GO:0006067) | 2.74881881 |
| 103 | sulfur amino acid catabolic process (GO:0000098) | 2.74280269 |
| 104 | amino-acid betaine metabolic process (GO:0006577) | 2.74184448 |
| 105 | flavonoid metabolic process (GO:0009812) | 2.73524854 |
| 106 | S-adenosylmethionine metabolic process (GO:0046500) | 2.72015490 |
| 107 | C4-dicarboxylate transport (GO:0015740) | 2.70877706 |
| 108 | positive regulation of blood coagulation (GO:0030194) | 2.69453239 |
| 109 | positive regulation of hemostasis (GO:1900048) | 2.69453239 |
| 110 | iron coordination entity transport (GO:1901678) | 2.69011430 |
| 111 | serine family amino acid catabolic process (GO:0009071) | 2.68990173 |
| 112 | cofactor catabolic process (GO:0051187) | 2.67422488 |
| 113 | regulation of cholesterol homeostasis (GO:2000188) | 2.65976751 |
| 114 | heme transport (GO:0015886) | 2.65382992 |
| 115 | cellular biogenic amine catabolic process (GO:0042402) | 2.65061750 |
| 116 | amine catabolic process (GO:0009310) | 2.65061750 |
| 117 | response to mercury ion (GO:0046689) | 2.63862894 |
| 118 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.61025380 |
| 119 | sterol transport (GO:0015918) | 2.59745822 |
| 120 | cholesterol transport (GO:0030301) | 2.59745822 |
| 121 | response to methylmercury (GO:0051597) | 2.59652075 |
| 122 | apical protein localization (GO:0045176) | 2.59497470 |
| 123 | positive regulation of steroid metabolic process (GO:0045940) | 2.58957860 |
| 124 | phospholipid efflux (GO:0033700) | 2.58865617 |
| 125 | acetyl-CoA metabolic process (GO:0006084) | 2.56310944 |
| 126 | arginine metabolic process (GO:0006525) | 2.55370624 |
| 127 | imidazole-containing compound metabolic process (GO:0052803) | 2.53997816 |
| 128 | nucleobase catabolic process (GO:0046113) | 2.52661701 |
| 129 | retinal rod cell development (GO:0046548) | 2.52370881 |
| 130 | organic acid catabolic process (GO:0016054) | 2.50924125 |
| 131 | carboxylic acid catabolic process (GO:0046395) | 2.50924125 |
| 132 | drug catabolic process (GO:0042737) | 2.49711421 |
| 133 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.49126978 |
| 134 | cellular modified amino acid catabolic process (GO:0042219) | 2.48986046 |
| 135 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.48983486 |
| 136 | opsonization (GO:0008228) | 2.47874990 |
| 137 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.47622563 |
| 138 | monocarboxylic acid catabolic process (GO:0072329) | 2.45513285 |
| 139 | cytolysis (GO:0019835) | 2.45135651 |
| 140 | negative regulation of sterol transport (GO:0032372) | 2.44021205 |
| 141 | negative regulation of cholesterol transport (GO:0032375) | 2.44021205 |
| 142 | phospholipid homeostasis (GO:0055091) | 2.43012018 |
| 143 | positive regulation of synapse maturation (GO:0090129) | 2.41900559 |
| 144 | positive regulation of glycolytic process (GO:0045821) | 2.40936110 |
| 145 | positive regulation of lipid catabolic process (GO:0050996) | 2.37849276 |
| 146 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.37523738 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.27121175 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.22577695 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.15584089 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.61258715 |
| 5 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.56878325 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.46231104 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.45108663 |
| 8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.39347545 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.08653289 |
| 10 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.06129542 |
| 11 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.01094702 |
| 12 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.98320596 |
| 13 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.88870912 |
| 14 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.87779216 |
| 15 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.79503938 |
| 16 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.78330310 |
| 17 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.78265916 |
| 18 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.77960012 |
| 19 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.73800388 |
| 20 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.72350122 |
| 21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.68078199 |
| 22 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.66745434 |
| 23 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.66620836 |
| 24 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.65055791 |
| 25 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.64309100 |
| 26 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.63547473 |
| 27 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.63498990 |
| 28 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.63498990 |
| 29 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.59920223 |
| 30 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.59342265 |
| 31 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.58019103 |
| 32 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.57532844 |
| 33 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.56476247 |
| 34 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.54150881 |
| 35 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.53909794 |
| 36 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.52571267 |
| 37 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.49311548 |
| 38 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.47614102 |
| 39 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.47387907 |
| 40 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.47368149 |
| 41 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.42313616 |
| 42 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.40970636 |
| 43 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.37938424 |
| 44 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.37551670 |
| 45 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.35531677 |
| 46 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.35212383 |
| 47 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.33396105 |
| 48 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.33396105 |
| 49 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.32695054 |
| 50 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.30542704 |
| 51 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.29196855 |
| 52 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.29184981 |
| 53 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.28524784 |
| 54 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.28194624 |
| 55 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.27876732 |
| 56 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26945302 |
| 57 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.26461292 |
| 58 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.26249748 |
| 59 | * TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.26105035 |
| 60 | STAT3_23295773_ChIP-Seq_U87_Human | 1.24394437 |
| 61 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.21639374 |
| 62 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.19194092 |
| 63 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.18070204 |
| 64 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.17413391 |
| 65 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.17031493 |
| 66 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.16875424 |
| 67 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.15775277 |
| 68 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.14383311 |
| 69 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.14152206 |
| 70 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.14060080 |
| 71 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.13323203 |
| 72 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.12540152 |
| 73 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.12431562 |
| 74 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.12245000 |
| 75 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.10945787 |
| 76 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.09794153 |
| 77 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.09594539 |
| 78 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.08680252 |
| 79 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.08404640 |
| 80 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.07254518 |
| 81 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.07193164 |
| 82 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.06837227 |
| 83 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.06753927 |
| 84 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.06242804 |
| 85 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.05649145 |
| 86 | TP53_16413492_ChIP-PET_HCT116_Human | 1.05345924 |
| 87 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.05146914 |
| 88 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.05064114 |
| 89 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.04424592 |
| 90 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.04265511 |
| 91 | TCF4_23295773_ChIP-Seq_U87_Human | 1.03983517 |
| 92 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.03015334 |
| 93 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.02837409 |
| 94 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.02248282 |
| 95 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.02016758 |
| 96 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00502600 |
| 97 | * AR_25329375_ChIP-Seq_VCAP_Human | 0.99138501 |
| 98 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.98124309 |
| 99 | * AR_19668381_ChIP-Seq_PC3_Human | 0.95902003 |
| 100 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.95020271 |
| 101 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.95020271 |
| 102 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.94511246 |
| 103 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.94304876 |
| 104 | FUS_26573619_Chip-Seq_HEK293_Human | 0.94215369 |
| 105 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.93894845 |
| 106 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.93788092 |
| 107 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.92621019 |
| 108 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.92303747 |
| 109 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92061539 |
| 110 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.91822115 |
| 111 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.91476925 |
| 112 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.90843484 |
| 113 | VDR_22108803_ChIP-Seq_LS180_Human | 0.90554523 |
| 114 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.90310389 |
| 115 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.89207605 |
| 116 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.88479079 |
| 117 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.86826688 |
| 118 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.86826688 |
| 119 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.86540982 |
| 120 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.86144540 |
| 121 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.85631537 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.08300888 |
| 2 | MP0005360_urolithiasis | 4.58819174 |
| 3 | MP0005365_abnormal_bile_salt | 4.25278462 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.06495425 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.32759485 |
| 6 | MP0005551_abnormal_eye_electrophysiolog | 2.87587440 |
| 7 | MP0003122_maternal_imprinting | 2.82766934 |
| 8 | MP0003252_abnormal_bile_duct | 2.73008320 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 2.57031936 |
| 10 | MP0003195_calcinosis | 2.44146150 |
| 11 | MP0004859_abnormal_synaptic_plasticity | 2.17100493 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.09633418 |
| 13 | MP0002090_abnormal_vision | 2.03136514 |
| 14 | MP0003329_amyloid_beta_deposits | 1.94304956 |
| 15 | MP0003880_abnormal_central_pattern | 1.89004768 |
| 16 | MP0002822_catalepsy | 1.87360856 |
| 17 | MP0006072_abnormal_retinal_apoptosis | 1.75910856 |
| 18 | MP0005332_abnormal_amino_acid | 1.73530974 |
| 19 | MP0002837_dystrophic_cardiac_calcinosis | 1.72366892 |
| 20 | MP0001666_abnormal_nutrient_absorption | 1.69905349 |
| 21 | MP0003868_abnormal_feces_composition | 1.68652211 |
| 22 | MP0002064_seizures | 1.64621353 |
| 23 | MP0005083_abnormal_biliary_tract | 1.63875011 |
| 24 | MP0009840_abnormal_foam_cell | 1.63780260 |
| 25 | MP0005253_abnormal_eye_physiology | 1.63160252 |
| 26 | MP0003635_abnormal_synaptic_transmissio | 1.61350950 |
| 27 | MP0003950_abnormal_plasma_membrane | 1.59324390 |
| 28 | MP0001486_abnormal_startle_reflex | 1.56241911 |
| 29 | MP0002272_abnormal_nervous_system | 1.55002805 |
| 30 | MP0003890_abnormal_embryonic-extraembry | 1.54785869 |
| 31 | MP0004270_analgesia | 1.54702497 |
| 32 | MP0001984_abnormal_olfaction | 1.52431680 |
| 33 | * MP0002118_abnormal_lipid_homeostasis | 1.51109151 |
| 34 | MP0009745_abnormal_behavioral_response | 1.50123977 |
| 35 | MP0001502_abnormal_circadian_rhythm | 1.49577037 |
| 36 | MP0003123_paternal_imprinting | 1.46745855 |
| 37 | MP0000920_abnormal_myelination | 1.45028985 |
| 38 | MP0009046_muscle_twitch | 1.44025829 |
| 39 | MP0005645_abnormal_hypothalamus_physiol | 1.41853731 |
| 40 | MP0002229_neurodegeneration | 1.37726571 |
| 41 | MP0005379_endocrine/exocrine_gland_phen | 1.35111196 |
| 42 | MP0004043_abnormal_pH_regulation | 1.33960884 |
| 43 | MP0004215_abnormal_myocardial_fiber | 1.33719696 |
| 44 | MP0002063_abnormal_learning/memory/cond | 1.32942709 |
| 45 | MP0003690_abnormal_glial_cell | 1.32530546 |
| 46 | MP0003787_abnormal_imprinting | 1.29333431 |
| 47 | MP0002572_abnormal_emotion/affect_behav | 1.28488001 |
| 48 | MP0003879_abnormal_hair_cell | 1.28079492 |
| 49 | MP0003121_genomic_imprinting | 1.25699790 |
| 50 | MP0000639_abnormal_adrenal_gland | 1.23478837 |
| 51 | MP0000604_amyloidosis | 1.23344127 |
| 52 | MP0004885_abnormal_endolymph | 1.19346245 |
| 53 | MP0004019_abnormal_vitamin_homeostasis | 1.19074608 |
| 54 | MP0003011_delayed_dark_adaptation | 1.17590520 |
| 55 | * MP0005195_abnormal_posterior_eye | 1.16914734 |
| 56 | MP0005646_abnormal_pituitary_gland | 1.16597432 |
| 57 | MP0001346_abnormal_lacrimal_gland | 1.15451404 |
| 58 | MP0005423_abnormal_somatic_nervous | 1.12898600 |
| 59 | MP0005448_abnormal_energy_balance | 1.11041112 |
| 60 | MP0005670_abnormal_white_adipose | 1.08477378 |
| 61 | MP0004036_abnormal_muscle_relaxation | 1.07014346 |
| 62 | MP0006276_abnormal_autonomic_nervous | 1.05957764 |
| 63 | MP0002067_abnormal_sensory_capabilities | 1.05691031 |
| 64 | MP0002138_abnormal_hepatobiliary_system | 1.03401580 |
| 65 | MP0003646_muscle_fatigue | 1.03262075 |
| 66 | MP0009697_abnormal_copulation | 1.02719867 |
| 67 | MP0004142_abnormal_muscle_tone | 1.01401775 |
| 68 | MP0008775_abnormal_heart_ventricle | 0.98202075 |
| 69 | MP0002909_abnormal_adrenal_gland | 0.98133261 |
| 70 | MP0005451_abnormal_body_composition | 0.98014064 |
| 71 | MP0009780_abnormal_chondrocyte_physiolo | 0.97581505 |
| 72 | MP0005187_abnormal_penis_morphology | 0.96626373 |
| 73 | MP0000778_abnormal_nervous_system | 0.96502106 |
| 74 | MP0002638_abnormal_pupillary_reflex | 0.96230862 |
| 75 | MP0004085_abnormal_heartbeat | 0.95819162 |
| 76 | MP0005386_behavior/neurological_phenoty | 0.95770968 |
| 77 | MP0004924_abnormal_behavior | 0.95770968 |
| 78 | MP0003633_abnormal_nervous_system | 0.95208709 |
| 79 | MP0003136_yellow_coat_color | 0.94558367 |
| 80 | * MP0001944_abnormal_pancreas_morphology | 0.93768379 |
| 81 | MP0003632_abnormal_nervous_system | 0.93735340 |
| 82 | MP0001485_abnormal_pinna_reflex | 0.92171169 |
| 83 | MP0003634_abnormal_glial_cell | 0.91336472 |
| 84 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.91276054 |
| 85 | MP0005167_abnormal_blood-brain_barrier | 0.90883736 |
| 86 | MP0002163_abnormal_gland_morphology | 0.90296528 |
| 87 | * MP0000609_abnormal_liver_physiology | 0.90223909 |
| 88 | MP0004130_abnormal_muscle_cell | 0.88728555 |
| 89 | MP0003631_nervous_system_phenotype | 0.88516215 |
| 90 | MP0002734_abnormal_mechanical_nocicepti | 0.87699004 |
| 91 | * MP0002882_abnormal_neuron_morphology | 0.86536104 |
| 92 | MP0003137_abnormal_impulse_conducting | 0.86180908 |
| 93 | MP0002928_abnormal_bile_duct | 0.84910508 |
| 94 | MP0001764_abnormal_homeostasis | 0.84434387 |
| 95 | MP0001661_extended_life_span | 0.83283286 |
| 96 | MP0002184_abnormal_innervation | 0.82988668 |
| 97 | MP0002876_abnormal_thyroid_physiology | 0.82279539 |
| 98 | MP0004084_abnormal_cardiac_muscle | 0.81985071 |
| 99 | MP0005248_abnormal_Harderian_gland | 0.81358307 |
| 100 | * MP0002078_abnormal_glucose_homeostasis | 0.80506898 |
| 101 | * MP0005319_abnormal_enzyme/_coenzyme | 0.80126702 |
| 102 | * MP0003953_abnormal_hormone_level | 0.79730685 |
| 103 | MP0002735_abnormal_chemical_nociception | 0.79698623 |
| 104 | MP0005084_abnormal_gallbladder_morpholo | 0.78090817 |
| 105 | MP0001756_abnormal_urination | 0.78072611 |
| 106 | MP0003119_abnormal_digestive_system | 0.77980635 |
| 107 | MP0002971_abnormal_brown_adipose | 0.77598133 |
| 108 | MP0000566_synostosis | 0.77381621 |
| 109 | * MP0002752_abnormal_somatic_nervous | 0.77295856 |
| 110 | MP0001501_abnormal_sleep_pattern | 0.77092129 |
| 111 | MP0003283_abnormal_digestive_organ | 0.75669384 |
| 112 | MP0005535_abnormal_body_temperature | 0.74585779 |
| 113 | MP0000955_abnormal_spinal_cord | 0.74305318 |
| 114 | MP0005409_darkened_coat_color | 0.73715151 |
| 115 | * MP0002066_abnormal_motor_capabilities/c | 0.73492607 |
| 116 | MP0008569_lethality_at_weaning | 0.73114468 |
| 117 | MP0004742_abnormal_vestibular_system | 0.73071225 |
| 118 | MP0002089_abnormal_postnatal_growth/wei | 0.72538003 |
| 119 | MP0001905_abnormal_dopamine_level | 0.72116897 |
| 120 | MP0005647_abnormal_sex_gland | 0.71901017 |
| 121 | MP0005595_abnormal_vascular_smooth | 0.70603918 |
| 122 | MP0000631_abnormal_neuroendocrine_gland | 0.70596010 |
| 123 | MP0005391_vision/eye_phenotype | 0.69747262 |
| 124 | MP0002557_abnormal_social/conspecific_i | 0.68989889 |
| 125 | MP0004133_heterotaxia | 0.68953182 |
| 126 | * MP0005220_abnormal_exocrine_pancreas | 0.68767462 |
| 127 | MP0002234_abnormal_pharynx_morphology | 0.68219296 |
| 128 | MP0001324_abnormal_eye_pigmentation | 0.67685735 |
| 129 | MP0005330_cardiomyopathy | 0.67183262 |
| 130 | MP0000230_abnormal_systemic_arterial | 0.66620794 |
| 131 | MP0004145_abnormal_muscle_electrophysio | 0.66317861 |
| 132 | * MP0002069_abnormal_eating/drinking_beha | 0.66124380 |
| 133 | MP0002127_abnormal_cardiovascular_syste | 0.65721185 |
| 134 | MP0004185_abnormal_adipocyte_glucose | 0.64396470 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital stationary night blindness (HP:0007642) | 5.99800184 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.51262100 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.44284384 |
| 4 | Deep venous thrombosis (HP:0002625) | 4.76584755 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 4.33369300 |
| 6 | Glomerulonephritis (HP:0000099) | 4.04832060 |
| 7 | Central scotoma (HP:0000603) | 3.94560011 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 3.94031257 |
| 9 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.90964614 |
| 10 | Xanthomatosis (HP:0000991) | 3.90132514 |
| 11 | Ketosis (HP:0001946) | 3.56062461 |
| 12 | Hypobetalipoproteinemia (HP:0003563) | 3.52073939 |
| 13 | Hyperventilation (HP:0002883) | 3.47210602 |
| 14 | Hepatoblastoma (HP:0002884) | 3.40223913 |
| 15 | Complement deficiency (HP:0004431) | 3.35881500 |
| 16 | Abnormality of macular pigmentation (HP:0008002) | 3.34519958 |
| 17 | Epidermoid cyst (HP:0200040) | 3.24529330 |
| 18 | Hypoglycemic coma (HP:0001325) | 3.24331299 |
| 19 | Ketoacidosis (HP:0001993) | 3.22709634 |
| 20 | Conjugated hyperbilirubinemia (HP:0002908) | 3.19311242 |
| 21 | Systemic lupus erythematosus (HP:0002725) | 3.04885402 |
| 22 | Decreased central vision (HP:0007663) | 3.01067939 |
| 23 | Hypoglycemic seizures (HP:0002173) | 3.00343548 |
| 24 | Potter facies (HP:0002009) | 2.99594633 |
| 25 | Facial shape deformation (HP:0011334) | 2.99594633 |
| 26 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.97694367 |
| 27 | Vascular calcification (HP:0004934) | 2.92856007 |
| 28 | Arthropathy (HP:0003040) | 2.87549691 |
| 29 | Hyperammonemia (HP:0001987) | 2.83921993 |
| 30 | Progressive cerebellar ataxia (HP:0002073) | 2.82267878 |
| 31 | Abnormality of methionine metabolism (HP:0010901) | 2.82067951 |
| 32 | Fat malabsorption (HP:0002630) | 2.77062653 |
| 33 | Hypolipoproteinemia (HP:0010981) | 2.76086357 |
| 34 | Cholecystitis (HP:0001082) | 2.75080388 |
| 35 | Abnormal gallbladder physiology (HP:0012438) | 2.75080388 |
| 36 | Joint hemorrhage (HP:0005261) | 2.73561158 |
| 37 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.68895972 |
| 38 | Hyperglycinemia (HP:0002154) | 2.67137380 |
| 39 | Abnormality of the common coagulation pathway (HP:0010990) | 2.66248805 |
| 40 | Hypoalphalipoproteinemia (HP:0003233) | 2.64489629 |
| 41 | Epileptic encephalopathy (HP:0200134) | 2.64472920 |
| 42 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.63438620 |
| 43 | Severe visual impairment (HP:0001141) | 2.62936212 |
| 44 | Neurofibrillary tangles (HP:0002185) | 2.62038353 |
| 45 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.60908706 |
| 46 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.60908706 |
| 47 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.60256833 |
| 48 | Osteomalacia (HP:0002749) | 2.56142146 |
| 49 | Abnormality of glycine metabolism (HP:0010895) | 2.55554711 |
| 50 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.55554711 |
| 51 | Abnormality of the corticospinal tract (HP:0002492) | 2.49284936 |
| 52 | Abnormal pancreas size (HP:0012094) | 2.45529250 |
| 53 | Nephritis (HP:0000123) | 2.42629239 |
| 54 | Mitral stenosis (HP:0001718) | 2.40951607 |
| 55 | Cardiovascular calcification (HP:0011915) | 2.40105607 |
| 56 | Scotoma (HP:0000575) | 2.39809102 |
| 57 | Spontaneous abortion (HP:0005268) | 2.38138358 |
| 58 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.33358810 |
| 59 | Hypercholesterolemia (HP:0003124) | 2.32195707 |
| 60 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.30469928 |
| 61 | Acanthocytosis (HP:0001927) | 2.29860124 |
| 62 | Skin nodule (HP:0200036) | 2.26407429 |
| 63 | Focal motor seizures (HP:0011153) | 2.22201186 |
| 64 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.21789058 |
| 65 | Abnormal gallbladder morphology (HP:0012437) | 2.20704845 |
| 66 | EEG with generalized epileptiform discharges (HP:0011198) | 2.19081057 |
| 67 | Hyperglycinuria (HP:0003108) | 2.17748951 |
| 68 | Hypothermia (HP:0002045) | 2.16922895 |
| 69 | Myokymia (HP:0002411) | 2.16548411 |
| 70 | Epileptiform EEG discharges (HP:0011182) | 2.15544595 |
| 71 | Generalized aminoaciduria (HP:0002909) | 2.15039166 |
| 72 | Scanning speech (HP:0002168) | 2.14468538 |
| 73 | Spastic gait (HP:0002064) | 2.13930202 |
| 74 | Symptomatic seizures (HP:0011145) | 2.13132391 |
| 75 | Abnormality of the intrinsic pathway (HP:0010989) | 2.10293546 |
| 76 | Drooling (HP:0002307) | 2.10122164 |
| 77 | Excessive salivation (HP:0003781) | 2.10122164 |
| 78 | Metabolic acidosis (HP:0001942) | 2.07442155 |
| 79 | Hypochromic microcytic anemia (HP:0004840) | 2.07328120 |
| 80 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.05984713 |
| 81 | Syncope (HP:0001279) | 2.04763316 |
| 82 | Enlarged kidneys (HP:0000105) | 2.04118931 |
| 83 | Abnormality of urine glucose concentration (HP:0011016) | 2.03825172 |
| 84 | Glycosuria (HP:0003076) | 2.03825172 |
| 85 | Proximal tubulopathy (HP:0000114) | 2.03507934 |
| 86 | Rickets (HP:0002748) | 2.03402258 |
| 87 | Abnormality of the lower motor neuron (HP:0002366) | 2.02028636 |
| 88 | Abnormality of complement system (HP:0005339) | 1.99539943 |
| 89 | Hyperbilirubinemia (HP:0002904) | 1.99260158 |
| 90 | Absence seizures (HP:0002121) | 1.97941613 |
| 91 | Hyperglycemia (HP:0003074) | 1.97502481 |
| 92 | Cholelithiasis (HP:0001081) | 1.97379937 |
| 93 | Cerebral inclusion bodies (HP:0100314) | 1.97324087 |
| 94 | Thickened helices (HP:0000391) | 1.96907645 |
| 95 | Steatorrhea (HP:0002570) | 1.95163381 |
| 96 | Fair hair (HP:0002286) | 1.95041269 |
| 97 | Hypophosphatemic rickets (HP:0004912) | 1.94507961 |
| 98 | Dialeptic seizures (HP:0011146) | 1.94505316 |
| 99 | Abnormality of vitamin metabolism (HP:0100508) | 1.94392333 |
| 100 | Hypsarrhythmia (HP:0002521) | 1.92636875 |
| 101 | Bifid scrotum (HP:0000048) | 1.92170710 |
| 102 | Abolished electroretinogram (ERG) (HP:0000550) | 1.92023500 |
| 103 | Prolonged QT interval (HP:0001657) | 1.91879685 |
| 104 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.91237818 |
| 105 | Nuclear cataract (HP:0100018) | 1.90951304 |
| 106 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.90880941 |
| 107 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.90880941 |
| 108 | Menorrhagia (HP:0000132) | 1.90002355 |
| 109 | Insidious onset (HP:0003587) | 1.88405274 |
| 110 | Termporal pattern (HP:0011008) | 1.88405274 |
| 111 | Gout (HP:0001997) | 1.87546692 |
| 112 | Hyperphosphaturia (HP:0003109) | 1.87387310 |
| 113 | Blue irides (HP:0000635) | 1.84987858 |
| 114 | Abnormality of serum amino acid levels (HP:0003112) | 1.84602488 |
| 115 | Late onset (HP:0003584) | 1.84549546 |
| 116 | Genetic anticipation (HP:0003743) | 1.84512693 |
| 117 | Intestinal atresia (HP:0011100) | 1.83736964 |
| 118 | Abnormality of the nasal septum (HP:0000419) | 1.83168766 |
| 119 | Zonular cataract (HP:0010920) | 1.82947542 |
| 120 | Agitation (HP:0000713) | 1.81446389 |
| 121 | Severe Myopia (HP:0011003) | 1.80317945 |
| 122 | Chorioretinal atrophy (HP:0000533) | 1.79324144 |
| 123 | Submucous cleft hard palate (HP:0000176) | 1.78547065 |
| 124 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.78431091 |
| 125 | Cerebral edema (HP:0002181) | 1.78152500 |
| 126 | Cone-rod dystrophy (HP:0000548) | 1.76955777 |
| 127 | Febrile seizures (HP:0002373) | 1.76556737 |
| 128 | Pheochromocytoma (HP:0002666) | 1.76514296 |
| 129 | Exercise-induced myalgia (HP:0003738) | 1.76044875 |
| 130 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.75765300 |
| 131 | Abnormality of the gallbladder (HP:0005264) | 1.74214365 |
| 132 | Neonatal hypoglycemia (HP:0001998) | 1.74184222 |
| 133 | Chronic hepatic failure (HP:0100626) | 1.73987921 |
| 134 | Dysmetria (HP:0001310) | 1.73023179 |
| 135 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.72635415 |
| 136 | Hemiparesis (HP:0001269) | 1.72302775 |
| 137 | Delayed CNS myelination (HP:0002188) | 1.71569517 |
| 138 | Status epilepticus (HP:0002133) | 1.69615632 |
| 139 | Diastasis recti (HP:0001540) | 1.68097080 |
| 140 | Congenital malformation of the right heart (HP:0011723) | 1.66744082 |
| 141 | Double outlet right ventricle (HP:0001719) | 1.66744082 |
| 142 | Gingival bleeding (HP:0000225) | 1.63776793 |
| 143 | Abnormal biliary tract physiology (HP:0012439) | 1.63416298 |
| 144 | Bile duct proliferation (HP:0001408) | 1.63416298 |
| 145 | Abnormal urine phosphate concentration (HP:0012599) | 1.62278685 |
| 146 | Alacrima (HP:0000522) | 1.61444610 |
| 147 | Abnormal urine output (HP:0012590) | 1.59600877 |
| 148 | Hepatocellular carcinoma (HP:0001402) | 1.59530639 |
| 149 | Gaze-evoked nystagmus (HP:0000640) | 1.55406127 |
| 150 | Hemorrhage of the eye (HP:0011885) | 1.55041673 |
| 151 | Papillary thyroid carcinoma (HP:0002895) | 1.54321969 |
| 152 | Vaginal fistula (HP:0004320) | 1.53429467 |
| 153 | Neoplasm of the liver (HP:0002896) | 1.52860772 |
| 154 | Anosmia (HP:0000458) | 1.52356432 |
| 155 | Abnormality of purine metabolism (HP:0004352) | 1.50948779 |
| 156 | Abnormality of nucleobase metabolism (HP:0010932) | 1.50917405 |
| 157 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.50848953 |
| 158 | Abnormality of the vitreous humor (HP:0004327) | 1.50187905 |
| 159 | Retinal atrophy (HP:0001105) | 1.49032171 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.11022566 |
| 2 | INSRR | 4.07694134 |
| 3 | NTRK3 | 2.64773177 |
| 4 | STK39 | 2.38140902 |
| 5 | FGFR3 | 2.28194631 |
| 6 | EPHA4 | 2.26147411 |
| 7 | PRPF4B | 2.25894249 |
| 8 | MAPK15 | 2.18718078 |
| 9 | BCKDK | 2.15579310 |
| 10 | SIK2 | 2.09379139 |
| 11 | WNK3 | 2.05687507 |
| 12 | PKN1 | 2.03153365 |
| 13 | ERBB4 | 1.89271328 |
| 14 | PIK3CA | 1.87045026 |
| 15 | BMPR1B | 1.82981291 |
| 16 | TNIK | 1.72974373 |
| 17 | SGK223 | 1.72886790 |
| 18 | SGK494 | 1.72886790 |
| 19 | CASK | 1.70297155 |
| 20 | STK38L | 1.63176893 |
| 21 | OXSR1 | 1.59892533 |
| 22 | PBK | 1.58490896 |
| 23 | PAK3 | 1.56983489 |
| 24 | FGFR2 | 1.52580163 |
| 25 | MARK1 | 1.52296522 |
| 26 | PAK6 | 1.50859127 |
| 27 | MAP3K13 | 1.50829115 |
| 28 | CAMK2D | 1.48962868 |
| 29 | BCR | 1.46034497 |
| 30 | MAP3K4 | 1.44985656 |
| 31 | EPHB1 | 1.44071277 |
| 32 | WNK4 | 1.42119628 |
| 33 | SIK1 | 1.32135946 |
| 34 | MAP2K4 | 1.31124724 |
| 35 | PINK1 | 1.30748911 |
| 36 | CAMK2B | 1.30424262 |
| 37 | PHKG2 | 1.29274202 |
| 38 | PHKG1 | 1.29274202 |
| 39 | CAMK1G | 1.21827943 |
| 40 | MAP3K7 | 1.21349823 |
| 41 | NTRK2 | 1.20212672 |
| 42 | TAOK3 | 1.18204134 |
| 43 | UHMK1 | 1.16219389 |
| 44 | CAMK2A | 1.15733551 |
| 45 | WNK1 | 1.08812340 |
| 46 | FER | 1.07043425 |
| 47 | KSR2 | 1.04270843 |
| 48 | MUSK | 1.03026515 |
| 49 | EPHA3 | 1.00240336 |
| 50 | CAMK2G | 0.99459104 |
| 51 | OBSCN | 0.97573007 |
| 52 | STK24 | 0.97562935 |
| 53 | SGK2 | 0.96834190 |
| 54 | MAP2K7 | 0.95218634 |
| 55 | DAPK2 | 0.93737975 |
| 56 | CAMKK2 | 0.93573240 |
| 57 | FGFR4 | 0.93073112 |
| 58 | CSNK1A1L | 0.92609482 |
| 59 | FGFR1 | 0.92105451 |
| 60 | ICK | 0.90190402 |
| 61 | ACVR1B | 0.88270258 |
| 62 | PRKCE | 0.85986543 |
| 63 | MAP3K9 | 0.85432340 |
| 64 | MAP3K2 | 0.83313480 |
| 65 | CDC42BPA | 0.82458519 |
| 66 | CDK5 | 0.81991172 |
| 67 | PNCK | 0.81774650 |
| 68 | DYRK1B | 0.81516600 |
| 69 | MARK2 | 0.81284668 |
| 70 | CSNK1G2 | 0.80227830 |
| 71 | PRKCG | 0.79607536 |
| 72 | STK3 | 0.79558910 |
| 73 | CDK3 | 0.78621381 |
| 74 | TYRO3 | 0.77212522 |
| 75 | CSNK1G3 | 0.77207802 |
| 76 | PRKCZ | 0.76603803 |
| 77 | STK11 | 0.76547460 |
| 78 | MET | 0.76356746 |
| 79 | FES | 0.75843443 |
| 80 | SGK3 | 0.75744334 |
| 81 | PRKCH | 0.75652675 |
| 82 | NEK9 | 0.75613424 |
| 83 | PRKAA1 | 0.74880627 |
| 84 | AKT3 | 0.74795935 |
| 85 | DYRK1A | 0.74619812 |
| 86 | GRK1 | 0.74295844 |
| 87 | NLK | 0.74184060 |
| 88 | PRKG1 | 0.73326000 |
| 89 | ARAF | 0.73303538 |
| 90 | CAMK1D | 0.72623863 |
| 91 | DYRK2 | 0.72252749 |
| 92 | CSNK1G1 | 0.71595734 |
| 93 | CAMK1 | 0.71492597 |
| 94 | MAPK7 | 0.71104543 |
| 95 | NEK6 | 0.71010346 |
| 96 | PIK3CG | 0.70908545 |
| 97 | MAP4K2 | 0.70506203 |
| 98 | ERBB2 | 0.67140529 |
| 99 | RET | 0.66949582 |
| 100 | STK38 | 0.66881836 |
| 101 | PTK2B | 0.66796266 |
| 102 | PRKAA2 | 0.66727738 |
| 103 | NTRK1 | 0.65670076 |
| 104 | IRAK2 | 0.65402347 |
| 105 | PRKD1 | 0.63437604 |
| 106 | SGK1 | 0.62887127 |
| 107 | PRKACB | 0.62767913 |
| 108 | CSNK1D | 0.62748022 |
| 109 | MKNK2 | 0.62401616 |
| 110 | CAMKK1 | 0.60817542 |
| 111 | LATS1 | 0.60678839 |
| 112 | MAPK11 | 0.60346155 |
| 113 | PDK1 | 0.59816130 |
| 114 | CSNK1E | 0.59281570 |
| 115 | MINK1 | 0.58412502 |
| 116 | KSR1 | 0.57475214 |
| 117 | PKN2 | 0.57132471 |
| 118 | RPS6KA3 | 0.55778104 |
| 119 | ADRBK2 | 0.55012404 |
| 120 | CAMK4 | 0.54840366 |
| 121 | MAPK13 | 0.54732521 |
| 122 | BRSK2 | 0.54690904 |
| 123 | PRKACG | 0.54626537 |
| 124 | BRD4 | 0.53838252 |
| 125 | ROCK2 | 0.53376303 |
| 126 | MAP3K1 | 0.53177744 |
| 127 | HIPK2 | 0.52509138 |
| 128 | PRKACA | 0.52269632 |
| 129 | RIPK1 | 0.50600443 |
| 130 | DMPK | 0.43743065 |
| 131 | ROCK1 | 0.42047210 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.52282417 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.30414410 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.88602151 |
| 4 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.67993031 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.60517674 |
| 6 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.39620993 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.10262199 |
| 8 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.09416511 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.08367740 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.06472018 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.02929782 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.94249646 |
| 13 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.92618016 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.91973552 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.80017349 |
| 16 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.75798319 |
| 17 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.70012876 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.69835552 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.66933765 |
| 20 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.62930690 |
| 21 | GABAergic synapse_Homo sapiens_hsa04727 | 1.62488210 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.61791804 |
| 23 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.61403487 |
| 24 | Peroxisome_Homo sapiens_hsa04146 | 1.60575407 |
| 25 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.47911066 |
| 26 | Bile secretion_Homo sapiens_hsa04976 | 1.36983521 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.36200329 |
| 28 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.36109324 |
| 29 | Nicotine addiction_Homo sapiens_hsa05033 | 1.36052949 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.32177133 |
| 31 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.31475759 |
| 32 | Retinol metabolism_Homo sapiens_hsa00830 | 1.24964257 |
| 33 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.20213985 |
| 34 | ABC transporters_Homo sapiens_hsa02010 | 1.18780123 |
| 35 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.16025251 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.13689719 |
| 37 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.13590550 |
| 38 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.10504601 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.09998911 |
| 40 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.09610521 |
| 41 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.07765197 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.04034880 |
| 43 | Insulin secretion_Homo sapiens_hsa04911 | 1.04029121 |
| 44 | Circadian entrainment_Homo sapiens_hsa04713 | 1.02985617 |
| 45 | Morphine addiction_Homo sapiens_hsa05032 | 1.02690510 |
| 46 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.00160441 |
| 47 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.95901460 |
| 48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.92465970 |
| 49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.91817856 |
| 50 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.91715524 |
| 51 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.90507030 |
| 52 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.89945433 |
| 53 | Carbon metabolism_Homo sapiens_hsa01200 | 0.84807524 |
| 54 | Lysine degradation_Homo sapiens_hsa00310 | 0.82955257 |
| 55 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.82057785 |
| 56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.81820882 |
| 57 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.81353923 |
| 58 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.79058581 |
| 59 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.78157624 |
| 60 | Phototransduction_Homo sapiens_hsa04744 | 0.78066473 |
| 61 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.77673898 |
| 62 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.72192339 |
| 63 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.69711405 |
| 64 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.69218469 |
| 65 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.67794334 |
| 66 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65228439 |
| 67 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.63103755 |
| 68 | Prion diseases_Homo sapiens_hsa05020 | 0.60072780 |
| 69 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.59440874 |
| 70 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.58885755 |
| 71 | Circadian rhythm_Homo sapiens_hsa04710 | 0.58821119 |
| 72 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.57508865 |
| 73 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.56911761 |
| 74 | Olfactory transduction_Homo sapiens_hsa04740 | 0.56566191 |
| 75 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.56154301 |
| 76 | Taste transduction_Homo sapiens_hsa04742 | 0.56125855 |
| 77 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.55447485 |
| 78 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.53833213 |
| 79 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.51873543 |
| 80 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.51626969 |
| 81 | Renin secretion_Homo sapiens_hsa04924 | 0.51325087 |
| 82 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.51276456 |
| 83 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.49705717 |
| 84 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.49176202 |
| 85 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.49167049 |
| 86 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.48822452 |
| 87 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.46956647 |
| 88 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.46917643 |
| 89 | Cocaine addiction_Homo sapiens_hsa05030 | 0.46887484 |
| 90 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.46180808 |
| 91 | Salivary secretion_Homo sapiens_hsa04970 | 0.45641909 |
| 92 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.43806295 |
| 93 | Insulin resistance_Homo sapiens_hsa04931 | 0.41288993 |
| 94 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.40617292 |
| 95 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.40066718 |
| 96 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.39712407 |
| 97 | Long-term depression_Homo sapiens_hsa04730 | 0.38268710 |
| 98 | Axon guidance_Homo sapiens_hsa04360 | 0.37240340 |
| 99 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.37137076 |
| 100 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.36446495 |
| 101 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.35253419 |
| 102 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33862903 |
| 103 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.33354570 |
| 104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.33181480 |
| 105 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.32610127 |
| 106 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.32132804 |
| 107 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.31933678 |
| 108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.30243767 |
| 109 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.29024124 |
| 110 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.26690885 |
| 111 | Mineral absorption_Homo sapiens_hsa04978 | 0.22889516 |
| 112 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.20883778 |
| 113 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.19357936 |

